Logo image of SNCRL

SYNCHRONOSS TECH - SNCR 8 3/8 06/30/26 (SNCRL) Stock Fundamental Analysis

NASDAQ:SNCRL - Nasdaq - US87157B3015 - Currency: USD

25.14  -0.06 (-0.24%)

Fundamental Rating

4

SNCRL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. SNCRL has only an average score on both its financial health and profitability. SNCRL may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SNCRL had positive earnings in the past year.
SNCRL had a positive operating cash flow in the past year.
In the past 5 years SNCRL reported 4 times negative net income.
SNCRL had a positive operating cash flow in 4 of the past 5 years.
SNCRL Yearly Net Income VS EBIT VS OCF VS FCFSNCRL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.57%, SNCRL is in the better half of the industry, outperforming 67.25% of the companies in the same industry.
Looking at the Return On Equity, with a value of 15.47%, SNCRL belongs to the top of the industry, outperforming 81.69% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.15%, SNCRL is doing good in the industry, outperforming 79.23% of the companies in the same industry.
Industry RankSector Rank
ROA 1.57%
ROE 15.47%
ROIC 7.15%
ROA(3y)-7.88%
ROA(5y)-9.34%
ROE(3y)-24.3%
ROE(5y)-25.21%
ROIC(3y)N/A
ROIC(5y)N/A
SNCRL Yearly ROA, ROE, ROICSNCRL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 2.65%, SNCRL is in the better half of the industry, outperforming 67.61% of the companies in the same industry.
With an excellent Operating Margin value of 13.22%, SNCRL belongs to the best of the industry, outperforming 80.99% of the companies in the same industry.
SNCRL has a Gross Margin of 77.51%. This is in the better half of the industry: SNCRL outperforms 75.35% of its industry peers.
In the last couple of years the Gross Margin of SNCRL has grown nicely.
Industry RankSector Rank
OM 13.22%
PM (TTM) 2.65%
GM 77.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.22%
GM growth 5Y8.61%
SNCRL Yearly Profit, Operating, Gross MarginsSNCRL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SNCRL is destroying value.
SNCRL has more shares outstanding than it did 1 year ago.
SNCRL has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SNCRL is higher compared to a year ago.
SNCRL Yearly Shares OutstandingSNCRL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
SNCRL Yearly Total Debt VS Total AssetsSNCRL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.35, we must say that SNCRL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SNCRL (-0.35) is worse than 71.13% of its industry peers.
SNCRL has a debt to FCF ratio of 14.07. This is a negative value and a sign of low solvency as SNCRL would need 14.07 years to pay back of all of its debts.
SNCRL's Debt to FCF ratio of 14.07 is in line compared to the rest of the industry. SNCRL outperforms 48.94% of its industry peers.
A Debt/Equity ratio of 6.22 is on the high side and indicates that SNCRL has dependencies on debt financing.
The Debt to Equity ratio of SNCRL (6.22) is worse than 84.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.22
Debt/FCF 14.07
Altman-Z -0.35
ROIC/WACC0.63
WACC11.38%
SNCRL Yearly LT Debt VS Equity VS FCFSNCRL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.02 indicates that SNCRL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.02, SNCRL is in the better half of the industry, outperforming 60.92% of the companies in the same industry.
SNCRL has a Quick Ratio of 2.02. This indicates that SNCRL is financially healthy and has no problem in meeting its short term obligations.
SNCRL has a Quick ratio of 2.02. This is in the better half of the industry: SNCRL outperforms 60.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
SNCRL Yearly Current Assets VS Current LiabilitesSNCRL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 473.91% over the past year.
Looking at the last year, SNCRL shows a small growth in Revenue. The Revenue has grown by 5.72% in the last year.
Measured over the past years, SNCRL shows a very negative growth in Revenue. The Revenue has been decreasing by -10.87% on average per year.
EPS 1Y (TTM)473.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.18%
Revenue 1Y (TTM)5.72%
Revenue growth 3Y-14.79%
Revenue growth 5Y-10.87%
Sales Q2Q%-1.76%

3.2 Future

The Earnings Per Share is expected to grow by 61.04% on average over the next years. This is a very strong growth
SNCRL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.84% yearly.
EPS Next Y54.59%
EPS Next 2Y61.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.24%
Revenue Next 2Y2.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNCRL Yearly Revenue VS EstimatesSNCRL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
SNCRL Yearly EPS VS EstimatesSNCRL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 -10 20

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.23, the valuation of SNCRL can be described as expensive.
Based on the Price/Earnings ratio, SNCRL is valued a bit cheaper than the industry average as 68.66% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 24.21, SNCRL is valued a bit more expensive.
With a Price/Forward Earnings ratio of 6.06, the valuation of SNCRL can be described as very cheap.
Based on the Price/Forward Earnings ratio, SNCRL is valued cheaper than 96.83% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SNCRL to the average of the S&P500 Index (20.44), we can say SNCRL is valued rather cheaply.
Industry RankSector Rank
PE 29.23
Fwd PE 6.06
SNCRL Price Earnings VS Forward Price EarningsSNCRL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNCRL indicates a rather cheap valuation: SNCRL is cheaper than 90.85% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SNCRL is valued a bit cheaper than the industry average as 79.58% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.64
EV/EBITDA 11.08
SNCRL Per share dataSNCRL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SNCRL's earnings are expected to grow with 61.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y61.04%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNCRL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SYNCHRONOSS TECH - SNCR 8 3/8 06/30/26

NASDAQ:SNCRL (5/9/2025, 8:22:20 PM)

25.14

-0.06 (-0.24%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners51.05%
Inst Owner ChangeN/A
Ins Owners10.47%
Ins Owner ChangeN/A
Market Cap289.11M
Analysts84.44
Price Target61.8 (145.82%)
Short Float %0.04%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.4
Dividend Growth(5Y)19.58%
DP92.42%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)411.79%
Min EPS beat(2)-160.62%
Max EPS beat(2)984.2%
EPS beat(4)3
Avg EPS beat(4)408.46%
Min EPS beat(4)-160.62%
Max EPS beat(4)984.2%
EPS beat(8)5
Avg EPS beat(8)216.3%
EPS beat(12)7
Avg EPS beat(12)146.01%
EPS beat(16)9
Avg EPS beat(16)147.04%
Revenue beat(2)0
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)1.06%
Revenue beat(8)1
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-3.79%
Revenue beat(16)4
Avg Revenue beat(16)-2.46%
PT rev (1m)10.91%
PT rev (3m)-6.21%
EPS NQ rev (1m)-17.95%
EPS NQ rev (3m)646.66%
EPS NY rev (1m)127.7%
EPS NY rev (3m)127.7%
Revenue NQ rev (1m)-2.97%
Revenue NQ rev (3m)-5.21%
Revenue NY rev (1m)-2.94%
Revenue NY rev (3m)-4.15%
Valuation
Industry RankSector Rank
PE 29.23
Fwd PE 6.06
P/S 1.67
P/FCF 21.64
P/OCF 10.22
P/B 9.71
P/tB N/A
EV/EBITDA 11.08
EPS(TTM)0.86
EY3.42%
EPS(NY)4.15
Fwd EY16.51%
FCF(TTM)1.16
FCFY4.62%
OCF(TTM)2.46
OCFY9.78%
SpS15.1
BVpS2.59
TBVpS-14.67
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.57%
ROE 15.47%
ROCE 9.05%
ROIC 7.15%
ROICexc 8.24%
ROICexgc 83.85%
OM 13.22%
PM (TTM) 2.65%
GM 77.51%
FCFM 7.69%
ROA(3y)-7.88%
ROA(5y)-9.34%
ROE(3y)-24.3%
ROE(5y)-25.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.22%
GM growth 5Y8.61%
F-Score7
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 6.22
Debt/FCF 14.07
Debt/EBITDA 4.63
Cap/Depr 87.32%
Cap/Sales 8.6%
Interest Coverage 1.52
Cash Conversion 70.62%
Profit Quality 289.93%
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z -0.35
F-Score7
WACC11.38%
ROIC/WACC0.63
Cap/Depr(3y)75.55%
Cap/Depr(5y)67.84%
Cap/Sales(3y)9.7%
Cap/Sales(5y)8.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)473.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.18%
EPS Next Y54.59%
EPS Next 2Y61.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.72%
Revenue growth 3Y-14.79%
Revenue growth 5Y-10.87%
Sales Q2Q%-1.76%
Revenue Next Year0.24%
Revenue Next 2Y2.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y464.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year158.9%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1378.18%
FCF growth 3YN/A
FCF growth 5Y3.22%
OCF growth 1Y50.19%
OCF growth 3Y79.37%
OCF growth 5Y-2.8%